Suppr超能文献

加拿大心力衰竭住院治疗当前及未来的经济负担:一项成本分析。

The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis.

作者信息

Tran Dat T, Ohinmaa Arto, Thanh Nguyen X, Howlett Jonathan G, Ezekowitz Justin A, McAlister Finlay A, Kaul Padma

机构信息

School of Public Health (Tran, Ohinmaa, Thanh), University of Alberta; Institute of Health Economics (Ohinmaa, Thanh), Edmonton; Department of Medicine (Howlett), University of Calgary, Calgary; Department of Medicine (Ezekowitz, McAlister, Kaul), University of Alberta; Canadian VIGOUR Centre (Ezekowitz, McAlister, Kaul), University of Alberta, Edmonton, Alta.

出版信息

CMAJ Open. 2016 Jul 21;4(3):E365-E370. doi: 10.9778/cmajo.20150130. eCollection 2016 Jul-Sep.

Abstract

BACKGROUND

Heart failure is a costly health condition and a major public health concern. We sought to examine the costs of hospital admissions for heart failure between fiscal years 2004 and 2013 in Canada and to model the future costs to 2030.

METHODS

Canadian Institutes for Health Information Discharge Abstract Database was used to identify admissions to hospital with heart failure as the primary diagnosis between fiscal years 2004 and 2013. Multiple linear regression models were used to calculate the trend in prevalence and extrapolate these to 2030. Canadian Institutes for Health Information patient cost estimates were used to identify costs of hospital admissions for heart failure. Generalized linear models were used to estimate average annual costs per heart failure patient. We conducted a sensitivity analysis including all admissions for heart failure in any diagnostic field.

RESULTS

In 2013, 45 600 (95% confidence interval [CI]: 43 800-47 200) patients were admitted with heart failure as the primary diagnosis, accounting for $482 (95% CI $464-$500) million. By 2030, we estimate 54 000 (95% CI 49 000-60 000) patients and costs of $722 (95% CI $650-$801) million, with older adults (age ≥ 80 yr) accounting for 52% of costs. Including admissions for which heart failure was a secondary diagnosis increases the total cost to $2.8 (95% CI $2.6-$3.0) billion in 2030.

INTERPRETATION

As in other developed countries, hospital costs related to heart failure in Canada are on the rise. Older adults are the main consumers of such hospital services. Strategies to improve outpatient care to reduce rates of admission for heart failure are needed.

摘要

背景

心力衰竭是一种成本高昂的健康状况,也是一个主要的公共卫生问题。我们试图研究2004财年至2013财年加拿大心力衰竭住院治疗的费用,并对到2030年的未来费用进行建模。

方法

使用加拿大卫生信息研究所出院摘要数据库来识别2004财年至2013财年期间以心力衰竭为主要诊断的住院病例。采用多元线性回归模型计算患病率趋势,并外推至2030年。利用加拿大卫生信息研究所的患者费用估计来确定心力衰竭住院治疗的费用。使用广义线性模型估计每位心力衰竭患者的年均费用。我们进行了敏感性分析,包括任何诊断领域中所有心力衰竭住院病例。

结果

2013年,有45600例(95%置信区间[CI]:43800 - 47200)患者以心力衰竭为主要诊断入院,费用为4.82亿加元(95%CI 4.64亿 - 5.00亿加元)。到2030年,我们估计有54000例(95%CI 49000 - 60000)患者,费用为7.22亿加元(95%CI 6.50亿 - 8.01亿加元),其中老年人(年龄≥80岁)占费用的52%。将心力衰竭作为次要诊断的住院病例包括在内,到2030年总费用增加到28亿加元(95%CI 26亿 - 30亿加元)。

解读

与其他发达国家一样,加拿大与心力衰竭相关的医院费用正在上升。老年人是此类医院服务的主要消费者。需要采取策略改善门诊护理,以降低心力衰竭的入院率。

相似文献

3
The Current and Future Hospitalization Cost Burden of Syncope in Canada.加拿大晕厥目前及未来的住院费用负担
CJC Open. 2020 Mar 4;2(4):222-228. doi: 10.1016/j.cjco.2020.02.009. eCollection 2020 Jul.
9
The current economic burden of illness of osteoporosis in Canada.加拿大骨质疏松症目前的疾病经济负担。
Osteoporos Int. 2016 Oct;27(10):3023-32. doi: 10.1007/s00198-016-3631-6. Epub 2016 May 11.

引用本文的文献

4
Heart failure: assessment of the global economic burden.心力衰竭:全球经济负担评估
Eur Heart J. 2025 Aug 14;46(31):3069-3078. doi: 10.1093/eurheartj/ehaf323.

本文引用的文献

4
Lifetime costs of medical care after heart failure diagnosis.心力衰竭诊断后的终身医疗费用。
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):68-75. doi: 10.1161/CIRCOUTCOMES.110.957225. Epub 2010 Dec 7.
6
Epidemiology and risk profile of heart failure.心力衰竭的流行病学和风险特征。
Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验